Biphasic effects of translational inhibitors on liver tyrosine aminotransferase.
Low doses of cycloheximide or emetine cause rat liver tyrosine aminotransferase activity to rise up to twice the control levels in 2 h. By contrast, in the same interval no changes, or only a slight decrease, are produced by either drug at high dosage. Adrenalectomised animals display the same pattern of response. High doses of either antibiotic virtually afford a complete inhibition of 14C-labelled amino acid incorporation into liver and plasma proteins, whereas no more than a 30% decrease is observed with low doses. When administered in the course of the induction by cortisol, high doses of inhibitor prevent any further change in tyrosine aminotransferase activity, stabilising it at the level already attained; low doses, while slightly affecting the synthetic phase evoked by cortisol, drastically interfere with the deinduction. Six hours after various doses of either inhibitor the tyrosine aminotransferase activity is markedly increased, this late effect being largely dependent on the presence of adrenals. The amino acid incorporating actitivy of the liver may exceed that of controls, as observed particularly after small doses of emetine.
D000315:Adrenalectomy; D000818:Animals; D003513:Cycloheximide / Q000494:pharmacology*; D004640:Emetine / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects; D006854:Hydrocortisone / Q000494:pharmacology*; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D008297:Male; D014176:Protein Biosynthesis / Q000187:drug effects*; D051381:Rats; D014444:Tyrosine Transaminase / Q000096:biosynthesis*
D003513:Cycloheximide; D014444:Tyrosine Transaminase; D006854:Hydrocortisone; D004640:Emetine